Just one week after opening our campaign to the public, Siren is now the #1 most raised campaign in the country across all of Regulation Crowdfunding, according to Kingscrowd. 🚀

For those who may be unfamiliar, Kingscrowd is the top independent platform tracking and ranking online startup investments. And right now, Siren is leading the pack nationwide. 🏆

To every single person who invested, shared, and rallied around our mission: THANK YOU. This momentum proves what’s possible when a community believes in building a future where all cancers become treatable – not someday, but now.

💥And a special shoutout to the Chris Graebe community — we see you! You showed up strong, and we’re so grateful to have you with us. Massive thanks to Chris Graebe, one of the most respected private market analysts and founder of The Press Room, for naming Siren his official 2025 Q2 Pick – we’re honored to have his endorsement!

This is just the beginning. Let’s keep the momentum going and drive the next-generation of cancer treatment!

Invest or increase your investment

Best,

Dr. Nicole K. Paulk, PhD

Founder & CEO, Siren Biotechnology